The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 3.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 13% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (3 analysts) rates it strong buy, with a mean price target of $49.
Riley Exploration Permian, Inc.
REPX · NYSE American · USD · Market cap $909M · 122 employees
Riley Exploration Permian, Inc., an independent oil and natural gas company, engages in the acquisition, exploration, development, and production of oil, natural gas, and natural gas liquids in Texas and New Mexico.
PASS · Titan Ethical · score 70.0Price as of 19 Nov 2026Daily close, not a live quote
Screened 2026-11-19 · the tape above runs as of 08:05 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price41.11 USD at the 19 Nov 2026 close
- Fair valueUnder review: our model's value is 1.46x the price, above our 1.35x limit.
- Our regime readDistribution, as of 16 Nov 2026
- Ethical screenPasses, score 70.0 out of 100
- OptionsOpen interest leans to puts (put/call 2.41)
- Last reviewed19 Nov 2026 (1 day ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-11-19).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options put/call open interest 2.41, read 2026-11-19
- Ethical passes the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its distribution label.
Riley Exploration Permian, Inc. holds its Distribution at $41.11. Consolidating, no directional conviction, held for 14 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 14 days |
| Price at the screen | $41.11 |
| Valuation | 8.69 trailing · 3.44 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 0.91 |
Five Screens: REPX's Results
PASS. All five recorded results clear their limits.
| Test | Figure | Limit | Status |
|---|---|---|---|
| Business activity | Permissible | Permissible core business | Pass |
| Debt load | 21.80% | Below 33% | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Pass |
| Receivables | 4.18% | Below 49% | Pass |
| Revenue purity | 0.17% | Below 5% | Pass |
Definitions, sources and threshold rules: ticker values-screen methodology.
The Ethical ReadWhy It Clears, in Plain English
Riley Exploration Permian, clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 22%, inside the ~33% line, and almost none of its income is interest, so it passes.
Read as at 2026-11-19. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when REPX's ethical verdict changes
Today REPX passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Fair value under review. Our model's value is 1.46x the price, above our 1.35x limit. We show no fair value, margin of safety or value read built on it until the review clears.
Model construction and limits: fair-value methodology.
The Street's RangeThird-party analyst targets: 3 covering, consensus Strong Buy. The average target sits +36% from the screen price.
Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-19 screen.
How our estimate and third-party targets differ.
The Business, in Plain Words| Forward P/E | 3.4xcheap for a company growing this fast |
| Trailing P/E | 8.7xvery cheap relative to earnings |
| EPS, trailing | 4.73 |
| EPS, forward | 11.94 |
| Revenue growth | +88.3%growing very fast |
| Profit margin | 17.3%healthy profit margins |
| Return on equity | 16.8%a solid return on shareholder capital |
| FCF yield | 21.92% |
| Dividend yield | 4.53% |
| Debt to equity | 0.38minimal debt: a conservative balance sheet |
| Current ratio | 0.41below 1: short-term bills exceed liquid assets |
| Beta | 0.91steadier than the market |
| Short interest, float | 0.06% |
| 52-week range | 24.09 - 54.57 |
| Market cap | $909M |
| Employees | 122 |
REPX-specific watchpoints · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Metric definitions and interpretation rules: ticker-page methodology.
Every Entry, As Written
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 12.1% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 13% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (3 analysts) rates it strong buy, with a mean price target of $49.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 11.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (3 analysts) rates it strong buy, with a mean price target of $49. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (3 analysts) rates it strong buy, with a mean price target of $49. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (3 analysts) rates it strong buy, with a mean price target of $49. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (3 analysts) rates it strong buy, with a mean price target of $49. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (3 analysts) rates it strong buy, with a mean price target of $49. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (3 analysts) rates it strong buy, with a mean price target of $49. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (3 analysts) rates it strong buy, with a mean price target of $49. It reported earnings in this window, a natural checkpoint for the thesis.
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 8.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it A. Technically it is holding around 53% above its long-term trend line with momentum reading overbought. Over the past year the shares are up 37%. Our forward projection puts the odds of a 10% gain over the next month near 29%. The street (3 analysts) rates it strong buy, with a mean price target of $49. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- 3 US Energy Stocks With Pricing Power as Inflation Keeps Rates Higher Yahoo Finance · 6d ago
- Zacks.com featured highlights include Jabil, Vista Energy and Riley Exploration Yahoo Finance · 7d ago
- 3 Stocks With Rising Cash Flows to Fortify Your Portfolio Yahoo Finance · 8d ago
- Is Riley Exploration Permian (REPX) a Great Value Stock Right Now? Yahoo Finance · 11d ago
- Riley Exploration Permian (REPX) Stock Gets Fair Value Boost On New Mexico Plans Yahoo Finance · 14d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $34.76 | +3.2% | · | $1,032 | +3.2% |
| 2 months | $39.10 | -8.3% | $0.40 | $927 | -7.3% |
| 3 months | $33.41 | +7.3% | $0.40 | $1,085 | +8.5% |
| 6 months | $26.49 | +35.4% | $0.80 | $1,384 | +38.4% |
| 1 year | $26.24 | +36.7% | $1.58 | $1,427 | +42.7% |
| 2 years | $24.64 | +45.5% | $3.08 | $1,580 | +58.0% |
| 3 years | $32.52 | +10.3% | $4.50 | $1,241 | +24.1% |
| 5 years | $36.33 | -1.3% | $7.04 | $1,181 | +18.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever REPX does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.